Study of ADI-PEG 20, Venetoclax and Azacitidine in Acute Myeloid Leukemia
Study of ADI-PEG 20, Venetoclax and Azacitidine in Acute Myeloid Leukemia
Active, not recruiting · NCT05001828 · Registry updated 2026-01-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of ADI-PEG 20, Venetoclax and Azacitidine in Acute Myeloid Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Active, not recruiting | Phase 1 | 2026-01-21 | NCT05001828 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Polaris Group | 5 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Levine Cancer Institute | Charlotte | United States | 110 |
| MD Anderson Cancer Center | Houston | United States | 589 |
| Sylvester Comprehensive Cancer Center | Miami | United States | 37 |